ZYVERSA THERAPEUTICS INC

1 institutions still hold ZYVERSA THERAPEUTICS INC as of Q2 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 98987D300·1 13F holders·last filed Jun 30, 2025

Market cap

—

▲ 5.3%

vs prior quarter

13F value held

$29.0B

58.0% inst. owned

of float

Holders

+29 QoQ

filers reporting

Activity

+25 / −6

+793 added · −802 reduced

this quarter

Concentration

—

CONCOURSE FINANCIAL GROUP SECURITIES, INC. #1

top holder share

AI Holders Summary · Q2 2025

1 institutions reported ZVSA in Q2 2025. Top-holder concentration data is loading. +29 net new institutions vs prior quarter — accumulation reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter

CONCOURSE FINANCIAL GROUP SECURITIES, INC.

CIK 0000752798

$00—Q2 2025